Hinge Health (HNGE) analyst forecast and price target
Analyst forecast
Consensus of 18 analyst ratings
Based on 10 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Barclays | Maintained | Overweight | $110.00 from $100.00 | Oct 12, 2026 |
| Needham | Maintained | Buy | $115.00 from $97.00 | Sep 30, 2026 |
| Baird | Maintained | Neutral | $90.00 from $85.00 | Sep 22, 2026 |
| Stifel | Maintained | Buy | $115.00 from $96.00 | Sep 8, 2026 |
| Truist Securities | Maintained | Buy | $112.00 from $85.00 | Aug 11, 2026 |
| Barclays | Maintained | Overweight | $100.00 from $97.00 | Aug 5, 2026 |
| Evercore ISI Group | Maintained | Outperform | $105.00 from $100.00 | Aug 5, 2026 |
| Wells Fargo | Maintained | Overweight | $103.00 from $90.00 | Aug 5, 2026 |
| Citizens | Maintained | Market Outperform | $107.00 from $96.00 | Aug 5, 2026 |
| Needham | Maintained | Buy | $97.00 from $76.00 | Aug 5, 2026 |
| RBC Capital | Maintained | Outperform | $110.00 from $75.00 | Aug 5, 2026 |
| Stifel | Maintained | Buy | $90.00 from $79.00 | Jul 27, 2026 |
| Citizens | Maintained | Market Outperform | $96.00 from $80.00 | Jul 27, 2026 |
| Canaccord Genuity | Maintained | Buy | $100.00 from $76.00 | Jul 21, 2026 |
| Morgan Stanley | Maintained | Overweight | $108.00 from $72.00 | Jul 13, 2026 |
| Keybanc | Maintained | Overweight | $125.00 from $90.00 | Jul 13, 2026 |
| Barclays | Maintained | Overweight | $97.00 from $70.00 | Jul 13, 2026 |
| Wells Fargo | Maintained | Overweight | $90.00 from $80.00 | Jun 24, 2026 |
| Baird | Maintained | Neutral | $65.00 from $55.00 | Jun 17, 2026 |
| Canaccord Genuity | Maintained | Buy | $76.00 from $65.00 | Jun 15, 2026 |
Frequently asked questions
What is the price target for HNGE stock?
The average 12-month analyst price target for Hinge Health (HNGE) is $106.70, with a high estimate of $115.00 and a low of $90.00, across 10 analysts.
Is HNGE a buy, sell, or hold?
Analysts covering Hinge Health currently average a Buy rating: 16 buy, 2 hold and 0 sell, from 18 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for HNGE?
The average price target of $106.70 implies 1.48% upside from the last price of $105.14.
What is the latest analyst rating on HNGE?
On Oct 12, 2026, Barclays maintained Hinge Health at Overweight with a price target of $110.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.